Announcement • 23h
Paxman Expands Global Regulatory Certifications for Cryocompression Device for Prevention of Chemotherapy-Induced Peripheral Neuropathy Paxman announced a series of significant regulatory milestones that strengthen its global quality management framework, supporting the forthcoming commercialisation of its expanded cryotherapy device portfolio to manage chemotherapy-induced side effects. Paxman has successfully extended the scope of its UK Conformity Assessed (UKCA), European Conformity (CE), International Organization for Standardization (ISO) 13485 and Medical Device Single Audit Program (MDSAP) certifications to include its new cryocompression technology for the management of chemotherapy-induced peripheral neuropathy (CIPN). The extended scope fulfils certification requirements in the UK and the EU and represent a key milestone toward approvals in Australia, Brazil, Canada, Japan and the United States for Paxman’s next-generation cryotherapy devices for managing chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced alopecia (CIA). These certifications strengthen the Company’s global regulatory position, and mark a critical step in Paxman’s strategy to expand access to innovative cooling technologies designed to mitigate the side effects of chemotherapy, supporting patients globally. Paxman’s solution for preventing CIPN delivers both controlled cooling and compression to the hands and feet before, during, and after chemotherapy infusion, making it a unique and differentiated product in the market. Recent Insider Transactions • Jun 29
Insider recently bought kr400k worth of stock On the 23rd of June, Per-Anders Johansson bought around 8k shares on-market at roughly kr50.05 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth kr3.0m. Insiders have collectively bought kr1.1m more in shares than they have sold in the last 12 months. Recent Insider Transactions • May 25
Insider recently bought kr150k worth of stock On the 21st of May, Per-Anders Johansson bought around 3k shares on-market at roughly kr50.00 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought kr680k more in shares than they have sold in the last 12 months. 
